INX Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Free Cash Flow QualityConsistent near one-to-one free cash flow to net income shows durable cash conversion. That quality supports recurring dividends, deleveraging or targeted M&A, and provides a buffer through cycles, underpinning long-term financial flexibility and capital allocation.
Diversified End MarketsBroad exposure to multiple end markets reduces single-industry cyclicality and smooths demand across business cycles. Diverse end markets enable cross-selling, product mix optimization, and lower revenue volatility, supporting a more resilient top line over multi-quarter horizons.
Value-Added Distribution ModelCombining logistics with technical support and formulation capabilities creates higher switching costs and stickier customer/principal relationships. This service-led distribution can sustain premium margins on specialty products and support share gains over time versus pure traders.
Bears Say
Margin CompressionMaterial margin deterioration in 2025 signals pressure on pricing or rising input/logistics costs that may persist. Sustained margin weakness would reduce free cash flow conversion and limit reinvestment capacity, making it harder to fund growth or maintain returns without structural fixes.
Higher LeverageRising leverage into the high 0.7–0.8x range constrains financial flexibility for bolt-on M&A or weathering revenue shocks. Higher net debt increases interest and refinancing sensitivity, which can limit strategic options and raise execution risk on longer-term growth initiatives.
Declining Capital EfficiencyA downward trend in ROE alongside negative EPS growth implies worsening returns on invested capital. Prolonged declines can signal structural margin or mix issues and may pressure reinvestment economics, making it harder to sustainably grow shareholder value without operational improvement.
IMCD N.V. News
INX FAQ
What was IMCD N.V.’s price range in the past 12 months?
Currently, no data Available
What is IMCD N.V.’s market cap?
IMCD N.V.’s market cap is CHF4.84B.
When is IMCD N.V.’s upcoming earnings report date?
IMCD N.V.’s upcoming earnings report date is Jul 29, 2026 which is in 2 days.
How were IMCD N.V.’s earnings last quarter?
IMCD N.V. released its earnings results on Apr 30, 2026. The company reported CHF1.357 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is IMCD N.V. overvalued?
According to Wall Street analysts IMCD N.V.’s price is currently Undervalued.
Does IMCD N.V. pay dividends?
IMCD N.V. does not currently pay dividends.
What is IMCD N.V.’s EPS estimate?
IMCD N.V.’s EPS estimate is 3.19.
How many shares outstanding does IMCD N.V. have?
IMCD N.V. has 59,107,998 shares outstanding.
What happened to IMCD N.V.’s price movement after its last earnings report?
IMCD N.V. reported an EPS of CHF1.357 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of IMCD N.V.?
Currently, no hedge funds are holding shares in CH:INX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IMCD N.V.
Founded in Rotterdam, the Netherlands, in 1995, IMCD N.V. operates as a leading global distributor and marketer of a diverse range of specialized chemicals and premium ingredients. Its extensive operations span across the Netherlands, the wider European continent, the Middle East, Africa, both North and South America, and the Asia-Pacific region. IMCD's comprehensive product portfolio serves numerous industries. For the pharmaceutical, agrochemical, and nutraceutical sectors, it provides essential active ingredients, excipients, formulation components, and compounds for regulated synthesis. Within personal care and cosmetics, the company supplies a wide array of offerings including active substances, UV filters, rheology modifiers, thickeners, emulsifiers, emollients, colorants, fragrances, and various functional additives for skin and hair products. Industrial applications benefit from resins, binders, functional fillers, and specialized solvents. Additionally, IMCD offers solutions for the food and beverage industry, focusing on enhancing taste, improving texture, and boosting nutritional value. The company also supports the energy sector with base oils, fuel and lubricant additives, and related fluids, alongside a broad spectrum of bio-based chemicals, catalysts, intermediates, and organic building blocks for various chemical processes.
INX Stock 12 Month Forecast
Average Price Target
CHF97.78